Loading Events

« All Events

  • This event has passed.

Protecting Patients with NERLYNX the only HER2-directed small molecule approved by the FDA in both eBC and mBC

August 13, 2020 @ 6:00 pm - 7:00 pm

Presented by: Dr. Francis Arena, NYU Langone Arena Oncology, Lake Success, New York
Sponsored by PUMA Biotechnology, Inc. 

Thursday, August 13, 2020 at 6:00pm-PDT

The topics below will be covered:
– Current unmet need in HER2+ Breast Cancer
– Review of clinical outcomes
– Tolerability management and support tools

To register click HERE

Details

Date:
August 13, 2020
Time:
6:00 pm - 7:00 pm
Event Category:

Organizer

Puma Biotechnology, Inc.

Venue

Webinar
View Venue Website